Intrexon Intrexon Completes $230M Public Offering The firm sold 5,609,756 shares of its common stock at $41 per share. Proceeds will be used for general corporate purposes and strategic acquisitions or investments. Intrexon Prices Public Offering Targeting $200M The synthetic biology firm is offering about 4.9 million shares of its common stock at $41 per share. Intrexon to Complete Acquisition of Exemplar Genetics Intrexon seeks to buy the remaining 49 percent stake in the firm, which creates animal models of human diseases in miniature pigs. Intrexon Buying Medistem for $26M NEW YORK (GenomeWeb News) – Intrexon today announced an agreement to acquire adult stem cell technology firm Medistem for about $26 million. Intrexon Reports Sharp Rise in Q3 Revenues NEW YORK (GenomeWeb News) – Reporting for the first time as a public company, synthetic biology company Intrexon said after the close of the market on Thursday that revenues in its third quarter more than doubled year over year. Sep 20, 2013 Intrexon's Q2 Revenues Rise Sharply as Loss Declines Sep 4, 2013 Mizuho Initiates Coverage of Intrexon with Buy Rating Aug 14, 2013 Intrexon Closes IPO Raising $184M Aug 8, 2013 Intrexon Goes Public, Shares Steeply Up on First Day of Trading Jul 30, 2013 Intrexon Prices IPO, Anticipates Net Proceeds of $113.5M Jul 9, 2013 Intrexon Files to Go Public with Stock Offering Targeting up to $125M in Proceeds May 2, 2013 Synthetic Biology Company Intrexon Raises $150M in Series F Preferred Investment Round Jan 3, 2013 Sanford-Burnham, Intrexon Strike iPSC Collaboration Jul 29, 2011 In Brief This Week: Caliper; PerkinElmer; Becton Dickinson; iGenix; Intrexon; Genedata, Takeda; EMBL-EBI May 31, 2011 Intrexon Raises $100M in Series E Round Apr 25, 2011 Intrexon Raises $66.9M Feb 1, 2011 Intrexon Buys Agarigen, Creates AgBio Division Jan 15, 2010 People in the News: Jan 15, 2010 Jan 8, 2010 Intrexon Raises $25M in Equity Financing Sep 1, 2009 Clinical Data to Get $1.5M from Sale of Non-core Assets Breaking News Ceres Nanosciences Wins $1.4M in NIH RADx Funding for Additional Wastewater Epidemiology Centers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer GenomeWeb Top 40 up 8 Percent in November, Outpacing Broader Market Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay ERS Genomics Licenses CRISPR-Cas9 IP to Cosmo Bio The Scan New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability. Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances. New mRNA Vaccines Offer Hope for Fighting Malaria A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines. Unique Germline Variants Found Among Black Prostate Cancer Patients Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.